We would love to hear your thoughts about our site and services, please take our survey here.
There are so many people that current analgesics don’t work for. Morphine based looses its effects over time, Anti inflammatory are contraindicated in so many illnesses and the use of antidepressants/anti epileptic for nerve pain is sometimes questioned so there is definitely need for alternatives.
Thought it would not be too difficult to get participants signed up for this phase 1 trial. Cannabis has been used for thousands of years and risks/side effects I would hope are much less than with the vast majority of other trial drugs.
All the little knocks add up. I thought with hemo taking so long to apply with FDA input the process would be smoother and to then suddenly be pulled up at the last hurdle causes reasonable doubt which obviously knocks confidence hence back to 1.50. I remember being told how wonderful the mint funding was and then a slow walk down in share price leading to a placement at 1.50. Vlad will have to provide a lot of information to install confidence. Just my frustrated opinion.
Very disappointed. Thought we had finally turned the corner. Feels like Mint all over again. A delay it may be but will have dented confidence again. I always use to say Vlad the scientist and not the business man. If we are going to get through the next month I pray the science is sound.